Joyce Liu

21PUBLICATIONS
202CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsPharmacology and pharmaceutical sciences not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 03, 2026
Maintenance therapy in gynecologic malignancies: Current and future state.

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Apr 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma.

Joyce F Liu, Nicoletta Colombo, Amit M Oza

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

|Apr 07, 2025
Shedding LIGHT on the changing landscape of poly-ADP ribose polymerase inhibitors in ovarian cancer.

Melissa K Frey, Joyce F Liu

|Apr 07, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.

Jung-Min Lee, Austin Miller, Peter G Rose

Pageof 4

Frequent Collaborators

6 joint publications

Ursula A Matulonis

5 joint publications

Panagiotis A Konstantinopoulos

4 joint publications

Alexi A Wright

4 joint publications

Oladapo Yeku